Immutep (IMMP) Enterprise Value Growth (1y) (2012 - 2025)
Immutep (IMMP) Enterprise Value Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immutep | 567.77 Mn | 567.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.51% |
| Jun 30, 2025 | 22.10% |
| Dec 31, 2024 | -54.23% |
| Jun 30, 2024 | -29.26% |
| Dec 31, 2023 | -50.32% |
| Jun 30, 2023 | -43.96% |
| Dec 31, 2022 | 38.12% |
| Jun 30, 2022 | -22.80% |
| Dec 31, 2021 | -80.98% |
| Jun 30, 2021 | -170.46% |
| Dec 31, 2020 | -186.19% |
| Jun 30, 2020 | -48.65% |
| Dec 31, 2019 | 24.86% |
| Jun 30, 2019 | 34.70% |
| Jun 30, 2018 | -93.33% |
| Jun 30, 2017 | 41.04% |
| Jun 30, 2016 | -196.68% |
| Jun 30, 2015 | 60.31% |
| Jun 30, 2014 | 39.57% |
| Jun 30, 2013 | -17.33% |